1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 18 Hits
  • 検索条件 : 絞込み (MeSH = Carcinoma, Pancreatic Ductal* / drug therapy)
生物種 リソース名 タイトル
ショウジョウバエ Inhibition of NAD-GPx4 axis and MEK triggers ferroptosis to suppress pancreatic ductal adenocarcinoma.
ヒト・動物細胞 PANC-1(RCB2095) , RBE(RCB1292) , Hep G2 , A549 , T24 , A172(RCB2530) Arachidonic acid induces pyroptosis via a non-autophagic function of mitophagy and enhances immunotherapy in a PDAC model.
遺伝子材料 pCMV-VSV-G-RSV-Rev (RDB04393) Quantitative Live Imaging Reveals Phase Dependency of PDAC Patient-Derived Organoids on ERK and AMPK Activity.
ヒト・動物細胞 T3M-4(RCB1021) Cytotoxic and senescence-inducing effects of BLU554 in pancreatic ductal adenocarcinoma: an in vitro study.
ヒト・動物細胞 KP4(RCB1005) Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer.
ヒト・動物細胞 PK-1(RCB1972) , KP-4(RCB1005) De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer.
ヒト・動物細胞 PK-59(RCB1901) Transcriptional deregulation by FOXM1-JUP signaling confers dual oncogenic drivers for pancreatic tumorigenesis and therapeutic resistance.
ヒト・動物細胞 hPSC-1(RCB3586) , hPSC-5(RCB3588) , hPSC-14(RCB3589) Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo.
ヒト・動物細胞 PK-8(RCB2700) Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer.
ヒト・動物細胞 PANC-1(RCB2095) , hPSC-5(RCB3588) , hPSC-14(RCB3589) A Role for Periostin Pathological Variants and Their Interaction with HSP70-1a in Promoting Pancreatic Cancer Progression and Chemoresistance.
実験動物マウス RBRC09881 Activation of STING in pancreatic cancer-associated fibroblasts exerts an antitumor effect by enhancing tumor immunity.
遺伝子材料 CSII-CMV-MCS-IRES2-Bsd (RDB04385) Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer.
ヒト・動物細胞 hPSC-5(RCB3588) , hPSC-14(RCB3589) Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer.
ショウジョウバエ DGRC#109027 Concurrent targeting of GSK3 and MEK as a therapeutic strategy to treat pancreatic ductal adenocarcinoma.
ヒト・動物細胞 PANC-1(RCB2095) CA9 and PRELID2; hypoxia-responsive potential therapeutic targets for pancreatic ductal adenocarcinoma as per bioinformatics analyses.
ヒト・動物細胞 PK-45H(RCB1973) , PK-59(RCB1901) , MIA Paca2(RCB2094) , PANC-1(RCB2095) , PK-1(RCB972) Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor.
ヒト・動物細胞 , ショウジョウバエ MIA Paca2(RCB2094) , PANC-1(RCB2095) Drosophila Screening Identifies Dual Inhibition of MEK and AURKB as an Effective Therapy for Pancreatic Ductal Adenocarcinoma.
ヒト・動物細胞 hPSC-1(RCB3586) , hPSC-5(RCB3588) , hPSC-14(RCB3589) Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma.